Developing new biomarkers is a priority for the Alzheimer’s Drug Discovery Foundation (ADDF). These tools are critical to the success of our mission to find effective ways to prevent and treat...
As the year 2017 rolled in, hopes were high that a few clinical trials would have a positive outcome, resulting in a possible new treatment for Alzheimer’s disease. Although there weren’t any...
Story on the new “Columbus Memory Project,” which offers every Columbus resident 65 or older a free test giving them a “memory number” as a baseline understanding of memory health, and will also...
Dear Dr. Mormino,
I’ve read that Alzheimer’s disease begins decades before it can be detected in people. Are researchers looking for ways to predict Alzheimer’s before then, maybe even in youngish...
Norma-Jean McLaren has been living with two electrodes implanted into her brain for almost a year. Following the recent publication of a new round of results in the trial, the team at Toronto Western...
Imagine this: You’re an Alzheimer’s researcher conducting a study that includes genetic testing to determine if participants carry the APOE4 gene, which is linked to both Alzheimer’s disease and...
Dear Dr. Roberts,
My father recently enrolled in GeneMatch, a new Alzheimer’s Prevention Registry program. He did a cheek swab and is waiting to be “matched” with appropriate studies. What are the...
Dear Dr. Grill,
My Mom is interested in taking part in a “transparent” preclinical trial on Alzheimer’s disease. As part of the study, she would undergo Positron Emission Tomography, also called a...
Families stalked by a remorseless killer that steals loved ones years before their time. Teams of scientists and health care professionals dedicated to finding the truth. If their work succeeds, the...
This month's expert is Pierre N. Tariot, MD, board-certified physician in internal medicine and geriatric psychiatry. Dr. Tariot is the Director of Banner Alzheimer's Institute and Co-Director,...
